Panel speakers to discuss hepatitis C prevention, treatment at Mayes College event

Mayes College of Healthcare Business and Policy at University of the Sciences is hosting a panel discussion on hepatitis C prevention and treatment, on Thursday, April 28, 2011, from 5 to 7 p.m. The event will take place in the McNeil Science and Technology Center (43rd St. at Woodland Ave., Philadelphia, Pa. 19104).

The panel of distinguished panel speakers will discuss the impact of the national strategy for preventing and treating hepatitis C and how the new pipeline of drugs will impact public health and patient care in the greater Philadelphia region.

Moderator Andrew Peterson, PharmD, PhD, Dean of Mayes College of Healthcare Business and Policy at USciences, will guide the panel that includes:

•Martin Black, MD, Chief of the Liver Unit and Liver Transplantation Director at Temple University School of Medicine
•Amy Jessop, PhD, MPH, Director of HepTREC at USciences' Mayes College
•Tracy Swan, Hepatitis/HIV Project Director for the Treatment Action Group
•John Ward, MD, Director of the Division of Viral Hepatitis at Centers for Disease Control and Prevention

Making the Connections: A Panel Discussion on Hepatitis C Prevention and Treatment is made possible by an unrestricted educational grant from AstraZeneca Pharmaceuticals. This panel discussion is a component of year-long theme focusing on hepatitis that Mayes College is incorporating into its culture through classroom work, events, speakers, and student activities.